Please use this identifier to cite or link to this item:
Title: Negative contrast cerenkov luminescence imaging of blood vessels in a tumor mouse model using [68Ga]gallium chloride
Authors: Steinberg, J.D.
Raju, A.
Chandrasekharan, P.
Yang, C.-T.
Khoo, K.
Abastado, J.-P.
Robins, E.G.
Townsend, D.W. 
Keywords: Blood vessels
Cerenkov luminescence imaging
Negative contrast imaging
Issue Date: 2014
Citation: Steinberg, J.D., Raju, A., Chandrasekharan, P., Yang, C.-T., Khoo, K., Abastado, J.-P., Robins, E.G., Townsend, D.W. (2014). Negative contrast cerenkov luminescence imaging of blood vessels in a tumor mouse model using [68Ga]gallium chloride. EJNMMI Research 4 (1) : 1-11. ScholarBank@NUS Repository.
Abstract: Background: Cerenkov luminescence imaging (CLI) is an emerging imaging technique where visible light emitted from injected beta-emitting radionuclides is detected with an optical imaging device. CLI research has mostly been focused on positive contrast imaging for ascertaining the distribution of the radiotracer in a way similar to other nuclear medicine techniques. Rather than using the conventional technique of measuring radiotracer distribution, we present a new approach of negative contrast imaging, where blood vessel attenuation of Cerenkov light emitted by [68Ga]GaCl3 is used to image vasculature. Methods: BALB/c nude mice were injected subcutaneously in the right flank with HT-1080 fibrosarcoma cells 14 to 21 days prior to imaging. On the imaging day, [68Ga]GaCl3 was injected and the mice were imaged from 45 to 90 min after injection using an IVIS Spectrum in vivo imaging system. The mice were imaged one at a time, and manual focus was used to bring the skin into focus. The smallest view with pixel size around 83 μm was used to achieve a sufficiently high image resolution for blood vessel imaging. Results: The blood vessels in the tumor were clearly visible, attenuating 7% to 18% of the light. Non-tumor side blood vessels had significantly reduced attenuation of 2% to 4%. The difference between the attenuation of light of tumor vessels (10% ± 4%) and the non-tumor vessels (3% ± 1%) was significant. Moreover, a necrotic core confirmed by histology was clearly visible in one of the tumors with a 21% reduction in radiance. Conclusions: The negative contrast CLI technique is capable of imaging vasculature using [68Ga]GaCl3. Since blood vessels smaller than 50 μm in diameter could be imaged, CLI is able to image structures that conventional nuclear medicine techniques cannot. Thus, the negative contrast imaging technique shows the feasibility of using CLI to perform angiography on superficial blood vessels, demonstrating an advantage over conventional nuclear medicine techniques. © 2014 Steinberg et al.
Source Title: EJNMMI Research
ISSN: 2191219X
DOI: 10.1186/2191-219X-4-15
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.


checked on Nov 23, 2021


checked on Nov 16, 2021

Page view(s)

checked on Nov 18, 2021

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.